Cerulean Pharma reported $47.82M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Adamis Pharmaceuticals ADMP:US 27.79M 7.41M
Agile Therapeutics AGRX:US 14.35M 9.57M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Bayer BAYN:GR 39.55B 1.3B
Biocept BIOC:US $ 47.58M 1.89M
Brainstorm Cell Therapeutics BCLI:US $ 19.26M 4.02M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Immunogen IMGN:US $ 373.87M 82.84M
Macrogenics MGNX:US $ 167.63M 50.57M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Seattle Genetics SGEN:US $ 2778.66M 7.4M
YTE INCY:US $ 3625.84M 337.75M